FDA accepts Exelixis treatment for priority review
SOUTH SAN FRANCISCO, Calif. | Drug developer Exelixis Inc. said Monday that the Food and Drug Administration has accepted its potential thyroid cancer treatment, carbozantinib, for priority review. The...
View ArticleEU approves Afinitor for certain breast cancers
GENEVA | Swiss drug maker Novartis AG says it has received European approval to market Afinitor for treatment of women with the most common form of advanced breast cancer. Afinitor is already approved...
View ArticleSchneider National requires hair sample drug test
MILWAUKEE | Schneider National Inc. has begun using hair samples to test potential employees for drugs, a process the Green Bay trucking company says does a better job of catching chronic drug abusers....
View Article23andMe seeks FDA approval for personal DNA test
WASHINGTON | Genetic test maker 23andMe is asking the Food and Drug Administration to approve its personalized DNA test in a move that, if successful, could boost acceptance of technology that is...
View ArticleCanine not your typical physical therapist
PHILADELPHIA | The newest member of the therapy team at Jefferson’s Magee Rehabilitation Hospital has perfect windswept blonde hair, loves long walks through Rittenhouse Square, and is a proud member...
View ArticleGreenville hospital warns of rare brain disease
COLUMBIA, S.C. | Eleven patients who had brain surgery at a Greenville hospital are being warned they might have been exposed to a rare, fatal brain disease. A patient who had surgery in February at...
View ArticleClik here to view.
If the money stops, so does the science
AURORA | In the science world, these three letters often mean big money: NIH. National Institutes of Health grants have long been vital for scientific research at Colorado universities and to the...
View ArticleClik here to view.
Signs of life: FRA celebrates opening of new wing for bioscience biz to grow...
AURORA | The days of bioscience startups outgrowing their home at the Fitzsimons Redevelopment Authority are likely over. The FRA on Wednesday unveiled the new wing at their headquarters, a...
View ArticleSummit aims to tackle rising number of Parkinson’s patients
AURORA | About 1 percent of people older than 65 can expect to deal with Parkinson’s disease. And with millions of baby boomers reaching 64, that means doctors can expect thousands more Parkinson’s...
View ArticleClik here to view.
Giles sees 80 percent of state’s bioscience biz coming from Anschutz
AURORA | From her offices in Denver, new Colorado BioScience Association President and CEO April Giles has her eyes fixed to the east. April Giles, Executive Vice President of the Colorado BioScience...
View Article
